Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4489 - 4496 of 11613 results
TCPA Regulatory Update – FCC Reviews Reply Comments on Opt-Out Call-Blocking, and Attorneys General and Carriers Join Forces to Fight Robocalls
September 18, 2019| Article| Viewpoint
Internet of Things Strategies for the Energy Sector
September 18, 2019| Blog| Viewpoint
Department of State Releases October 2019 Visa Bulletin
September 18, 2019| Alert| Viewpoint
Mintz Adds Ex-Cooley Life Sciences Trademark Pro In NY
September 18, 2019| News
PTAB Says Mass. Biotech's Milk Patent Ineligible For Review
September 18, 2019| News
GAO Report Sheds Light on Drug Manufacturers’ Expanded Access Programs
September 17, 2019| Blog| Viewpoint
Top Boston Lawyer Wields Clout to Help Community
September 17, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.